Illustrative photograph. A routine blood count does not replace a specific assessment of von Willebrand disease.
A normal platelet count can be reassuring in some settings, but it does not establish that an injection is suitable for someone with von Willebrand disease. This bleeding disorder affects a protein involved in clotting. The number of platelets and the way bleeding is controlled are related questions, not interchangeable results.
For clients considering joint or tendon PRP, there are two separate decisions: whether PRP has a worthwhile role for the musculoskeletal problem, and whether blood collection and injection can be undertaken with an appropriate bleeding plan. Neither decision should be made from a full blood count alone. Known von Willebrand disease, a previous bleeding investigation or an unusual history of bleeding belongs in the assessment before treatment is arranged.
The aim is proportionate care rather than a blanket refusal. Many people have mild disease and need no daily treatment. Even so, a procedure can expose a bleeding tendency that has caused little difficulty in ordinary life. Specialist advice helps establish the right setting and precautions, or whether an elective injection should wait. [1,2,4]
What is von Willebrand disease?
Von Willebrand factor is a protein that helps platelets attach at the site of a damaged blood vessel. It also carries and protects clotting factor VIII. If there is too little of it, or it does not work normally, the first steps in controlling bleeding may be less effective. This is different from simply having too few platelets. [3,5]
The condition is usually inherited and can affect people of any sex. Its severity varies. Easy bruising, recurrent nosebleeds, gum bleeding, heavy periods and bleeding after dental work or surgery can be clues. Some people are diagnosed only after a procedure or after a relative is found to have the condition. Severe forms can also cause bleeding into muscles or joints. [1,2]
A diagnosis therefore needs more context than the word mild or a single result marked within range. The type of disease, past bleeding and the planned procedure all contribute to the assessment. Someone with little everyday bleeding may still need specific advice before an intervention that breaks the skin.
Why can the platelet count be normal?
A full blood count measures the number of platelets, along with red and white blood cells. It does not directly measure the amount or activity of von Willebrand factor. The CDC explains that screening blood tests are often normal in von Willebrand disease and that more specific tests are needed. [3]
A normal platelet count should therefore not be described as clearance for PRP. Likewise, routine clotting tests do not reliably exclude mild disease. The activated partial thromboplastin time, often called APTT, may be normal in mild von Willebrand disease, and the prothrombin time is normal in most people with the condition. [3]
The practical distinction is between counting the cells and understanding the whole clotting process. A reassuring full blood count does not cancel a confirmed bleeding-disorder diagnosis, a substantial bleeding history or advice already given by a haematology team. Additional investigations should be selected because they answer a clinical question, not because a standard PRP panel looks complete.
Which blood tests answer the specific question?
International diagnostic guidance identifies von Willebrand factor antigen, platelet-dependent von Willebrand factor activity and factor VIII activity as core specific tests. Antigen testing concerns how much protein is present; activity testing concerns how it works. Further tests may be needed to clarify a subtype. The results need interpretation alongside the bleeding history. [5]
Levels can vary over time. Von Willebrand factor can rise with bleeding, trauma, pregnancy and other physical stresses. The international guideline advises diagnostic testing at a baseline state of health, and NHS information explains that repeated tests over days or weeks may be needed. A single blood sample does not always settle a borderline investigation. [1,3,5]
These are diagnostic principles, not a prescription for everyone considering PRP to order every test. For someone with an established diagnosis, existing specialist records may explain which results are relevant and when they need updating. For someone with unexplained bleeding, a proper clinical investigation comes before a decision about an elective injection.
Does the type of von Willebrand disease matter?
Yes. Type 1 generally involves a partial reduction in the amount of von Willebrand factor. Type 2 involves a problem with its function and has several subtypes. Type 3 involves very little or no von Willebrand factor and is usually more severe. These distinctions affect how bleeding is assessed and which treatments may work. [1,5]
The same medicine is not suitable for every type. For example, international management guidance explains that desmopressin is ineffective in type 3 and is generally contraindicated in type 2B because it can lower the platelet count. This is one reason a familiar medicine name or an old procedural plan cannot be copied without checking the current situation. [4]
The disease label alone is also insufficient. Past responses to treatment, other illnesses, prescribed medicines and the site of the planned injection matter. A personalised plan should be based on the actual diagnosis and bleeding pattern, rather than assuming that all type 1 disease is trivial or that all type 2 disease is managed identically.
What does the bleeding history add?
A useful history includes bleeding after tooth extraction, surgery, childbirth, significant injuries and previous injections. Recurrent nosebleeds, heavy menstrual bleeding, prolonged bleeding from small wounds and a family history help establish the wider pattern. The important detail is what happened and what treatment was needed, not simply whether bruising occurs. [1,2,5]
International guidance supports structured bleeding-assessment tools in appropriate settings. It also says that such a tool should not be used to decide against specific testing when the probability is already higher, such as with an affected first-degree relative or a concerning history referred for specialist review. A short questionnaire is not a substitute for that assessment. [5]
An uncomplicated vaccination or blood test is useful information, but it does not guarantee that a deeper tendon or joint injection carries the same risk. The planned site and procedure need their own consideration. Equally, an old episode of heavy bleeding should be understood in context rather than automatically treated as a permanent bar to all procedures.
Does using your own blood make PRP risk-free?
No. PRP is prepared from the client's own blood, but obtaining that blood still involves a needle, and treatment involves another needle at the intended site. Autologous describes where the material comes from. It does not establish normal clotting, remove the possibility of bleeding or prove that the procedure is worthwhile for a particular condition.
Concentrating platelets should not be presented as a treatment for von Willebrand disease. The disorder concerns a wider clotting process, and standard care may involve medicines or factor replacement selected by a specialist. PRP research for a joint or tendon condition does not show that PRP corrects this bleeding disorder. [1,4]
The distinction also matters when discussing benefit. A carefully managed bleeding risk would not prove PRP will improve the joint or tendon problem. Conversely, evidence that PRP may help a particular musculoskeletal condition would not remove the need for a bleeding plan. Both questions have to be answered separately before a treatment recommendation can be meaningful.
What do PRP recommendations actually cover?
A 2025 international expert consensus addressed PRP in selected infectious, cancer-related and haematological conditions. It recommends investigating significant blood-count abnormalities before musculoskeletal PRP. However, the authors explicitly state that their recommendations do not cover procedure-related bleeding risk or reduced efficacy caused by platelet abnormalities. Most recommendations are based on expert opinion because direct evidence is limited. [6]
That scope is important for someone with von Willebrand disease. Guidance about a platelet count in another clinical situation is not a universal safety threshold for this condition. It cannot replace disease-specific advice about clotting, nor should a statement that PRP is permitted in one blood disorder be extended to a different one. [4,6]
The consensus is also limited to musculoskeletal injections. It should not automatically be treated as clearance for scalp, facial or other procedures. The location, purpose and details of the planned treatment need to be clear to the clinicians considering it. A broad statement that PRP is natural is not a substitute for this assessment.
How is a procedure-specific bleeding plan made?
NHS guidance advises people with von Willebrand disease to seek advice from their specialist team before surgery, procedures or dental treatment, and to tell the clinician performing the treatment about the diagnosis. International management guidance likewise emphasises individual planning according to the procedure, bleeding history and type of disease. [1,4]
Depending on those details, specialist treatment may involve tranexamic acid, desmopressin or von Willebrand factor replacement. These are not interchangeable options, and their mention here is not an instruction to start them. A response trial or other assessment may be needed before desmopressin is used. Some people need different treatment, and some low-risk procedures may require a less intensive approach. [1,4]
A joint or tendon PRP injection should not be assigned the same regimen as dental work merely because both are called minor procedures. The management guideline specifically notes variation between procedures and the risk of overtreating some superficial interventions. Any proposed plan needs to fit the actual injection and the individual's circumstances, not a schedule taken from a blog.
What if aspirin, an anticoagulant or pain medicine is prescribed?
The complete medicine list belongs in the assessment, including non-prescription painkillers, herbal products and supplements. NHS guidance cautions about medicines such as aspirin and non-steroidal anti-inflammatory drugs because they can worsen bleeding. It also advises checking herbal remedies and supplements with a pharmacist or doctor. [1]
That does not mean a prescribed antiplatelet medicine or anticoagulant should be stopped independently to obtain PRP. Some medicines protect against serious cardiovascular problems. The international management guideline supports necessary antiplatelet or anticoagulant treatment when indicated, with individual assessment and reassessment of bleeding risk. [4]
The prescribing clinician and haematology team should guide any change. The same applies to preventive treatment for the bleeding disorder: taking an extra dose, missing a dose or reusing a previous procedural prescription without advice can create problems. If a safe, agreed plan is not in place, an elective injection can wait while the medical priorities are clarified.
What if the diagnosis is uncertain or the latest level is normal?
Unexplained prolonged bleeding deserves assessment even when a routine blood count is normal. A relative's diagnosis, unusually heavy bleeding after dental work or repeated troublesome nosebleeds may change which investigations are appropriate. NHS guidance recommends a GP assessment for relevant symptoms and family history, with referral to a haematologist when indicated. [1,3]
A normal recent von Willebrand factor result also needs context in someone with a previously confirmed diagnosis. The international diagnostic guideline advises reconsidering the diagnosis rather than simply removing it when levels normalise with age. The relationship between a higher level and a person's bleeding symptoms is not sufficiently clear to assume that the previous risk has disappeared. [5]
This does not mean every borderline result represents disease or that everyone needs indefinite testing. It means diagnostic decisions should be made deliberately, using the original evidence and current clinical picture. A cosmetic or musculoskeletal treatment appointment is not the place to erase a bleeding-disorder diagnosis on the strength of an isolated result.
Which symptoms take priority over an elective PRP appointment?
Active significant bleeding takes priority. NHS guidance advises going to A&E for a nosebleed lasting longer than 10 to 15 minutes or seeming very heavy, or for an injury or cut where bleeding cannot be stopped. Blood in the urine or black or dark-red stools needs urgent GP or NHS 111 advice. Follow any emergency instructions already provided by the specialist team. [1]
New joint pain, swelling and stiffness can occur with bleeding into a joint in severe disease. Such symptoms should not automatically be attributed to arthritis, a sports injury or a need for PRP. The existing bleeding-disorder plan and prompt clinical advice are more important than proceeding with an elective injection. [1,2]
Planning a PRP discussion at The Wellness
For clients with known or suspected von Willebrand disease, the starting point is a clear account of the musculoskeletal problem and the bleeding history. Existing haematology letters, the confirmed type, relevant results, current medicines and previous procedural advice can help establish what further information is needed.
The purpose is to decide whether PRP is a sensible option at all and whether specialist input or a different treatment setting is required. This article does not confirm that PRP can be provided for every bleeding disorder, or that specialist bleeding treatment is included in a routine appointment. A decision to defer can be the appropriate outcome of careful assessment.
A useful plan keeps the expected benefit, the bleeding precautions and the alternatives visible together. Rehabilitation, another form of assessment or treatment without an injection may be more appropriate for the joint or tendon problem. An informed decision is more valuable than treating a normal platelet count as permission to proceed.
Discuss joint or tendon PRP suitability with The Wellness
Frequently asked questions
Can I have PRP if I have von Willebrand disease?
It requires an individual assessment. The diagnosis, bleeding history, intended injection and specialist advice matter. A normal platelet count or a mild disease label is not enough to confirm suitability. PRP may need to be deferred or another approach chosen. [1,4]
Does a normal full blood count rule out von Willebrand disease?
No. Routine screening tests can be normal. Specific tests assess von Willebrand factor quantity and activity and factor VIII, interpreted with the clinical history. Repeat testing may be needed. [3,5]
Will concentrating my platelets correct the bleeding disorder?
PRP should not be presented as a treatment for von Willebrand disease. Management of the disorder concerns the clotting process and may require specialist medicines or factor replacement. Evidence for a joint or tendon treatment does not establish correction of a bleeding disorder. [1,4]
Should I take tranexamic acid or desmopressin before PRP?
Only under an agreed clinical plan. The need for treatment and the choice depend on the disease type, bleeding history and procedure. Desmopressin does not suit every type and can be inappropriate in some circumstances. Do not start or alter these medicines from this article. [4]
Can I stop my blood thinner to make the injection safer?
Do not stop prescribed treatment independently. Its benefits and the bleeding risk need to be considered together by the relevant clinicians. An elective injection should wait if the medicine and bleeding plan are unresolved. [4]
What if my von Willebrand factor level has returned to normal?
A single normal result does not automatically remove a previous confirmed diagnosis. Levels vary and may rise with age or physical stress. The original diagnosis and current bleeding history need review before conclusions are drawn about procedure safety. [3,5]
Sources
Leeds Teaching Hospitals NHS Trust, von Willebrand's disorder
CDC, Diagnosing von Willebrand Disease
ASH ISTH NHF WFH, 2021 guidelines on management of von Willebrand disease
ASH ISTH NHF WFH, 2021 guidelines on diagnosis of von Willebrand disease
Eymard and colleagues, 2025 GRIIP consensus on PRP and comorbidities